SCHEMBL23787659

SCHEMBL23787659

CCc1cc(-c2cc(CC)c(/N=N/c3cc(S(N)(=O)=O)c4ccccc4c3N)c(CC)c2)cc(CC)c1/N=N/c1cc(S(N)(=O)=O)c2ccccc2c1N

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SENP2 Q9HC62 4/20 0.49
▸ SENP1 Q9P0U3 4/20 0.49
▸ SUMO2 P61956 3/20 0.49
▸ SUMO1 P63165 3/20 0.49
▸ SENP7 Q9BQF6 3/20 0.49
▸ ALDH1A1 P00352 2/20 0.49
▸ APP P05067 2/20 0.49
▸ THRB P10828 2/20 0.49
▸ HPGD P15428 2/20 0.49
▸ ALOX12 P18054 2/20 0.49
▸ RECQL P46063 2/20 0.49
▸ SENP3 Q9H4L4 2/20 0.49
▸ MEN1 O00255 1/20 0.49
▸ MAPT P10636 1/20 0.49
▸ SNCA P37840 1/20 0.49
▸ BLM P54132 1/20 0.49
▸ KMT2A Q03164 1/20 0.49
▸ TDP1 Q9NUW8 1/20 0.49
▸ ENPP2 Q13822 2/20 0.48
▸ CYP3A4 P08684 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23787617 0.89 SENP2 (0.64) SENP2SENP1SUMO2SUMO1SENP7
SCHEMBL23787657 0.88 ALDH1A1 (0.57) SENP2SENP1SUMO2SUMO1SENP7
SCHEMBL23787518 0.85 ALDH1A1 (0.59) SENP2SENP1SUMO2SUMO1SENP7
SCHEMBL23787520 0.83 APP (0.52) SENP2SENP1SUMO2SUMO1SENP7
SCHEMBL23787661 0.82 APP (0.51) SENP2SENP1SUMO2SUMO1SENP7
SCHEMBL23787625 0.82 ALDH1A1 (0.54) SENP2SENP1SUMO2SUMO1SENP7
SCHEMBL23787683 0.81 SENP2 (0.51) SENP2SENP1SUMO2SUMO1SENP7
SCHEMBL23787773 0.81 SENP2 (0.60) SENP2SENP1SUMO2SUMO1SENP7
SCHEMBL23787622 0.78 APP (0.78) SENP2SENP1SUMO2SUMO1SENP7
SCHEMBL13856934 0.78 APP (0.78) SENP2SENP1SUMO2SUMO1SENP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210275548-A1 NOVEL DNA POLYMERASE GAMMA INHIBITOR AND USES THEREOF ACIBADEM MEHMET ALI AYDINLAR UNIVERSITESI (TR) 2021-09-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210275548-A1 NOVEL DNA POLYMERASE GAMMA INHIBITOR AND USES THEREOF POLG, POLB, POLA1 SENP2 1558/4885SENP1 1087/4885SUMO2 2270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback